Massachusetts General Hospital operates the largest hospital-based research program in the United States. Here are some facts and figures about our research efforts.
With a budget of $1B in 2019, Mass General is home to the largest hospital-based research enterprise in the United State. Mass General ranks 1st among independent hospitals in the amount of annual funding received from NIH, and 10th among all institutions.
Research at Mass General takes place in 30 departments, centers and institutes across the hospital. The Department of Medicine has the largest research portfolio at 21% of the total. We also have significant research programs taking place in our Thematic Research Centers (13%), the Mass General Cancer Center (11%), Neurology (11%), Radiology 10%), Surgery (6%) and Psychiatry (6%) and many others.
The research community includes more than 8,500 people and covers 1.3M square feet of research space in Boston, Cambridge and Charlestown. We have 2,000 principal investigators and there are 1,200 postdoctoral fellows and 700 graduate students training in research at Mass General at any given time. Over one-third of the 3,000 physicians at Mass General are also conducting research.
To date, more than 100,000 patients have consented to have their blood samples and health histories added to the Partners Biobank at Mass General, so we can learn more about the genetic basis of disease
The Office of the Scientific Director has established the Mass General Research Institute Blog to promote the work of investigators at Massachusetts General Hospital. Since its launch in 2017, the blog has received more than 125,000 views from 96,000 visitors.
Since the inception of the MGH Research Scholars program in 2011, a total of 55 Mass General investigators have received crucial unrestricted funding ($100,000 per year for five years) to support the game-changing ideas that are too early or unproven for traditional forms of funding.
|Mass General Outcomes||FY16||FY17||FY18||FY19|
|Material Transfer Agreements||1067||1360||1374||1537|
|Royalty and Licensing Outcome||$77M||$87.7M||$94.6M||$298M|